Jazz Pharmaceuticals JAZZ Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $293.1M+417% | —— | $251.41M+16.9% | -$718.47M-526% | -$92.5M-533% | ||
| $9.1M-12.5% | $9.43M-0.9% | $9.88M+27.0% | $11.93M+52.7% | $10.4M+35.9% | ||
| $74.5M+10.0% | $70.85M+0.9% | $88.13M+47.5% | $64.45M+13.8% | $67.7M+10.2% | ||
| $408.2M-5.0% | $362.52M-9.0% | $474.62M+19.0% | $88.84M-73.2% | $429.8M+60.8% | ||
| $19.7M+41.7% | $16.73M+25.9% | $15.18M+40.7% | $12.95M+82.6% | $13.9M+101% | ||
| $123.1M+173% | -$372.16M-92.5% | -$327.8M— | -$640.95M-149% | -$169M+37.8% | ||
| -$78.5M+90.4% | $0— | -$10.83M-104% | -$124.49M+22.7% | -$813.5M-1,338% | ||
| $452.4M+182% | —— | —— | -$671.98M-667% | -$551M-776% | ||
| $388.5M-6.6% | $345.79M-10.3% | $459.44M+18.4% | $75.89M-76.6% | $415.9M+59.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Jazz Pharmaceuticals generate?
- Jazz Pharmaceuticals (JAZZ) generated $1.3B in operating cash flow over the trailing twelve months.
- What is Jazz Pharmaceuticals's free cash flow?
- After $64.6M of capital expenditures, Jazz Pharmaceuticals's free cash flow was $1.3B over the trailing twelve months, down 16.1% year over year.
- Where does Jazz Pharmaceuticals's cash flow data come from?
- Every line is extracted from Jazz Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
